A Gene Expression Signature Predicts Survival of Patients with Stage I Non-Small Cell Lung Cancer

Our results indicate that gene expression signatures from several datasets can be reconciled. The resulting signature is useful in predicting survival of stage I NSCLC and might be useful in informing treatment decisions.